Federal Register / Vol. 66, No. 87 / Friday, May 4, 2001 / Notices 22585

achieving the applicant’s goals and

objectives will be evaluated, and how,

once the plan has been completed, its

impact on environmental health and

human exposure issues in the

applicant’s community will be assessed.

6. Staffing, Management System, and

Facilities (5 Percent)

The extent to which the applicant

describes the staff available or

anticipated to conduct the planning

activities and how they will be

managed. The applicant must describe

the organizational setting and facilities

available to support the development of

the plan, to accumulate and analyze

data and other information related to

planning. Applicants should also

describe planning to provide IRB review

when biomonitoring programs are

implemented and discuss the impact of

the requirements of the Clinical

Laboratory Improvement Amendments

of 1988 (CLIA) on their plan.

7. Budget (Not Scored)

The extent to which the applicant

provides a detailed budget and narrative

justification consistent with stated

objectives and planned program

activities.

H. Other Requirements

Provide CDC with the original plus

two copies of:

1. Annual progress reports, no more

than 30 days after the end of the report

period;

2. Financial status report, no more

than 90 days after the end of the budget

period;

3. Final financial report and

performance report, no more than 90

days after the end of the project period;

and

4. Completed planning document, no

later than the end of the third quarter of

year two.

Send all reports to the Grants

Management Specialist identified in the

‘‘Where to Obtain Additional

Information’’ section of this

announcement.

The following additional

requirements are applicable to this

program. For a complete description of

each, see Attachment I in the

application kit.

AR–7 Executive Order 12372 Review

AR–10 Smoke-Free Workplace

Requirements

AR–11 Healthy People 2010

AR–12 Lobbying Restrictions

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under

sections 301 and 317 of the Public

Health Service Act, 42 U.S.C. sections

241 and 247b, as amended. The catalog

of Federal Domestic Assistance number

is 93.283.

J. Where To Obtain Additional

Information

This and other CDC announcements

can be found on the CDC home page

Internet address—http://www.cdc.gov

Click on ‘‘Funding’’ then ‘‘Grants and

Cooperative Agreements.’’

To receive additional written

information and to request an

application kit, call 1–888–GRANTS4

(1–888–472–6874). You will be asked to

leave your name and address and will

be instructed to identify the

Announcement number of interest.

If you have questions after reviewing

the contents of all the documents,

business management technical

assistance may be obtained from: Sonia

V. Rowell, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention,

2920 Brandywine Road, Room 3000,

(MS E–13), Atlanta, GA 30341–4146,

Telephone: (770) 488–2724, E-mail

address: svp1@cdc.gov.

For program technical assistance

contact: Dayton T. Miller, Ph.D.,

National Center for Environmental

Health, Centers for Disease Control and

Prevention, 4770 Buford Highway, NE

(MS F–18), Atlanta, GA 30341–3724,

Telephone: (770) 488–4452, E-mail

address: dtm1@cdc.gov.

Dated: April 30, 2001.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 01–11215 Filed 5–3–01; 8:45 am]

BILLING CODE 4163–19–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

CDC Advisory Committee on HIV and

STD Prevention: Meeting

In accordance with section l0(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: CDC Advisory Committee on

HIV and STD Prevention.

Times and Dates: 8:30 a.m.–5 p.m.,

June 4, 2001. Place: Holiday Inn, 130

Clairmont Ave, Decatur, Georgia 30030.

Place: 8:30 a.m.–5 p.m., June 5, 2001.

Corporate Square Office Park, Corporate

Square Boulevard, Building 8, 1st Floor

Conference Room, Atlanta, Georgia

30329.

Status: Open to the public, limited

only by the space available. The meeting

room will accommodate approximately

100 people.

Purpose: This Committee is charged

with advising the Director, CDC,

regarding objectives, strategies, and

priorities for HIV and STD prevention

efforts including maintaining

surveillance of HIV infection, AIDS, and

STDs, the epidemiologic and laboratory

study of HIV/AIDS and STDs,

information/education and risk

reduction activities designed to prevent

the spread of HIV and STDs, and other

preventive measures that become

available.

Matters to be Discussed: Agenda items

include issues pertaining to (1) HIV

prevention-care interface (2) HRSA–

CDC linkages in terms of preventing

STDs other than HIV (3) Syphilis

elimination. Agenda items are subject to

change as priorities dictate.

For Further Information Contact:

Paulette Ford, Committee Management

Analyst, National Center for HIV, STD,

and TB Prevention, 1600 Clifton Road,

NE, Mailstop E–07, Atlanta, Georgia

30333. Telephone 404/639–8008, fax

404/639–3125, e-mail pbf7@cdc.gov.

The Director, Management Analysis

and Services Office, has been delegated

the authority to sign Federal Register

Notices pertaining to announcements of

meetings and other committee

management activities, for both the

Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: April 30, 2001.

John Burckhardt,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention.

[FR Doc. 01–11218 Filed 5–3–01; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 01D–0185]

Draft Guidance for Industry on

Providing Regulatory Submissions in

Electronic Format—Postmarketing

Expedited Safety Reports; Availability

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing the